CircFOXM1 silencing represses cell proliferation, migration and invasion by regulating miR-515-5p/ADAM10 axis in

Gong-Xue Liu1, Tao Zheng, Yong Zhang

  • 1Department of Urology, Wuhan Fourth Hospital, Puai Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China.

Anti-Cancer Drugs
|August 13, 2021
PubMed

Insights

Circular FOXM1 (circFOXM1) promotes prostate cancer (PCa) progression by upregulating ADAM10 via sponging miR-515-5p. Silencing circFOXM1 or ADAM10 inhibits PCa growth and metastasis, offering potential therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Circular FOXM1 (circFOXM1) is implicated in various cancers.
  • The specific role of circFOXM1 in prostate cancer (PCa) progression remained unclear.
  • Understanding circFOXM1's regulatory mechanisms in PCa is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the role and regulatory mechanism of circFOXM1 in prostate cancer (PCa).
  • To explore the relationship between circFOXM1, miR-515-5p, and ADAM10 in PCa.
  • To evaluate the therapeutic potential of targeting the circFOXM1/miR-515-5p/ADAM10 axis in PCa.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) and western blot to assess circFOXM1 and ADAM10 expression.
  • Cell proliferation, migration, invasion, and cell cycle assays to evaluate functional impacts.
  • Dual-luciferase reporter and RNA pull-down assays to confirm molecular interactions.
  • In-vivo tumor formation assays to assess therapeutic efficacy.

Main Results:

  • circFOXM1 and ADAM10 were significantly upregulated in PCa tissues and cells.
  • circFOXM1 silencing inhibited PCa cell proliferation, migration, invasion, and induced cell cycle arrest.
  • circFOXM1 directly sponged miR-515-5p, which in turn targeted ADAM10, forming the circFOXM1/miR-515-5p/ADAM10 axis.
  • Inhibition of circFOXM1 or ADAM10 suppressed tumor growth in vivo.

Conclusions:

  • circFOXM1 drives prostate cancer (PCa) progression through the miR-515-5p/ADAM10 pathway.
  • circFOXM1 and ADAM10 represent potential therapeutic targets for PCa treatment.
  • This study provides a theoretical basis for further research into PCa progression and treatment strategies.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.5K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K